Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Vericel Corp | Director | Common Stock | 11.9K | $661K | $55.54 | Nov 13, 2024 | Direct |
Vericel Corp | Director | Restricted Stock Unit | 3.2K | $57.6K | $18.00 | May 1, 2024 | Direct |
Invivyd, Inc. | Director | Stock Option (Right to Buy) | 100K | May 21, 2024 | Direct | ||
Vericel Corp | Director | Stock Option (Right to Buy) | 6K | Nov 13, 2024 | Direct | ||
ACCELERON PHARMA INC | SVP, CFO and Treasurer | Common Stock | 0 | $29.37 | Nov 19, 2021 | Direct | |
ACCELERON PHARMA INC | SVP, CFO and Treasurer | Option to Purchase Common Stock | 0 | Nov 19, 2021 | Direct | ||
Decibel Therapeutics, Inc. | Director | Common Stock | 0 | $5.03 | Sep 25, 2023 | Direct | |
Decibel Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | Sep 25, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VCEL | Vericel Corp | Nov 13, 2024 | 3 | -$363K | 4 | Nov 15, 2024 | Director |
VCEL | Vericel Corp | Aug 7, 2024 | 6 | -$295K | 4 | Aug 9, 2024 | Director |
IVVD | Invivyd, Inc. | May 21, 2024 | 1 | $0 | 4 | May 23, 2024 | Director |
IVVD | Invivyd, Inc. | May 21, 2024 | 0 | $0 | 3 | May 23, 2024 | Director |
VCEL | Vericel Corp | May 1, 2024 | 4 | $0 | 4 | May 3, 2024 | Director |
DBTX | Decibel Therapeutics, Inc. | Sep 25, 2023 | 3 | $0 | 4 | Sep 25, 2023 | Director |
DBTX | Decibel Therapeutics, Inc. | Jun 13, 2023 | 2 | $0 | 4 | Jun 14, 2023 | Director |
VCEL | Vericel Corp | May 3, 2023 | 2 | $0 | 4 | May 5, 2023 | Director |
VCEL | Vericel Corp | Apr 27, 2023 | 2 | $0 | 4 | Apr 28, 2023 | Director |
DBTX | Decibel Therapeutics, Inc. | Oct 10, 2022 | 1 | $0 | 4 | Oct 12, 2022 | Director |
DBTX | Decibel Therapeutics, Inc. | Oct 10, 2022 | 0 | $0 | 3 | Oct 12, 2022 | Director |
VCEL | Vericel Corp | Apr 27, 2022 | 4 | $0 | 4 | Apr 29, 2022 | Director |
XLRN | ACCELERON PHARMA INC | Nov 19, 2021 | 6 | $0 | 4 | Nov 22, 2021 | SVP, CFO and Treasurer |
XLRN | ACCELERON PHARMA INC | Sep 23, 2021 | 13 | -$3.01M | 4 | Sep 24, 2021 | SVP, CFO and Treasurer |